In today’s podcast, Crinetics co-founders Dr. Scott Struthers and Dr. Steve Betz share their views and experiences in drug discovery and development, revealing what it really takes to bring a new medication from concept to patients.
Clinical Trials
New 3-Month Octreotide Formulation Enters Phase 3 Testing for Acromegaly
December 4, 2025
In an important new development Swiss-based Debiopharm entered a Phase 3 trial of a new Octreotide formulation. The company is currently recruiting patients for the study. Debio 4126 is a sustained-release formulation designed to improve the convenience of somatostatin analogue (SSA) therapy for the treatment of acromegaly.
Oxytocin, the forgotten hormone?
November 26, 2025
Oxytocin is classically known for its role in labor and breastfeeding; however, a growing body of literature has demonstrated oxytocin’s role in several physiologic domains both in animal models and humans. Oxytocin, in fact, regulates metabolism, mood, social functioning, sexual function, and bone and muscular health.
Latest news
February 16, 2022
This is a partial list of the current clinical trials for new medications. If you are interested in finding more information, we've provided links to each study. You can also check the NIH National Library